FRANKFURT: European shares ended slightly lower on Monday, with tariff-sensitive auto stocks down after US President Donald ...

EUROPEAN shares ended slightly lower on Monday, with tariff-sensitive auto stocks down after US President Donald Trump’s ...

AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical trial involving patients with uncontrolled or treatment-resistant hypertension. In the trial, patients who ...

Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

AstraZeneca (LSE:AZN) recently experienced a weekly price move of 2% amid announcements that could have supported its ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients with uncontrolled or treatment-resistant hypertension, AstraZeneca ...

European shares ended slightly lower on Monday as investors react to further US tariff rhetoric. Car-makers, considered ...

Baxdrostat is an investigational highly selective, oral, small molecule designed to inhibit aldosterone synthase.

The European Union is prepared to unleash a €21bn (£18.2bn) retaliation against Donald Trump after the US president announced ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

(Sharecast News) - London stocks closed higher on Monday, buoyed by geopolitical trade developments after US president Donald Trump announced plans to impose 30% tariffs on imports from the European ...